FEATURES OF APOPTOSIS, FORMATION OF MEMBRANE-RELEASED MICROPARTICLES AND CYTOKINES PRODUCTION IN CASE OF LYMPHOCYTE DAMAGE IN SYNTROPY OF BRONCHIAL ASTHMA AND OBESITY IN YOUNG PATIENTS

The aim of the research was to study the characteristics of apoptosis, membrane-released microparticles (MRM) formation and cytokines production in case of lymphocyte damage in young patients with bronchial asthma, depending on body mass index. 224 people were examined. In all the patients there was done an assessment of the excessive weight and determination of obesity degree as well as clinical and functional examination; there was performed a determination of cytokines and adipokines; the lymphocytes were separated from the peripheral blood. The number of apoptotic cells was estimated in accordance with the standard protocol; the number of MRM was counted. It was found out that in case of bronchial asthma and obesity syntropy, even at a young age, more often there are patients with moderate and severe clinical course; besides, the severity of bronchial-obstructive syndrome in patients of this group is more significant with the tendency to decrease in FEV₁ and FEV₁/FVC. In the group of young patients with obesity combined with bronchial asthma in the peripheral blood there was imbalance of both adipokines and cytokines, characterized by evident increase in the levels of pro-inflammatory leptin, IL-4, IL-6, TNF-α, and the decrease in potential body weight regulator IL-15, and at the same time low levels of anti-inflammatory adiponectin. In patients with obesity, the percentage of cells in apoptosis was significantly lower compared to both those in control with obesity and patients with normal body weight. The number of MRM, as cell damage indicator, significantly increased in the group with obesity. It can be assumed that the imbalance of cytokines, adipokines and mechanisms of programmed cell death is a possible pathogenetic factor in asthma and obesity syntropy.

bronchial asthma, lymphocyte apoptosis, cytokines, leptin, adiponectin

1. Агеева Е.С., Штыгашева О.В., Иптышев В.М., Буторин Н.Н., Цуканов В.В., Рязанцева Н.В. Роль апоптоза в дисрегуляции локального и системного иммунитета при Helicobacter pilory-инфекции // Бюллетень сибирской медицины. 2010. Т.9, №5. С.13-18. https://doi.org/10.20538/1682-0363-2010-5-13-18

2. Астафьева Н.Г., Гамова И.В., Удовиченко Е.Н., Перфилова И.А. Ожирение и бронхиальная астма // Лечащий врач. 2014. №4,5.

3. Байдакова Е.В., Унгуряну Т.Н., Бузинов Р.В., Гудков А.Б. Заболеваемость бронхиальной астмой населения Архангельской области // Экология человека. 2011. №12. С.8-13.

4. Курбачева О.М., Жестков А.В., Нагаткин Д.А., Кулагина В.В., Нагаткина О.В. Современный взгляд на иммунопатогенез бронхиальной астмы // Российский аллергологический журнал. 2016. №2. С.10-14.

5. Невзорова В.А., Пазыч С.А., Бархатова Д.А., Кудрявцева В.А. Роль процессов клеточной гибели в развитии воспаления при бронхиальной астме // Тихоокеанский медицинский журнал. 2006. №2. С.54-58.

6. Скибо Ю.В., Курмаева Н.Ш. Особенности апоптоза лимфоцитов у больных лёгкой и тяжёлой атопической бронхиальной астмой // Практическая медицина. 2012. №6(61). С.62-68.

7. Устинова Т. И., Медведева Н. Н., Салмина А. Б., Малиновская Н. А. Морфологическая характеристика нейро-глиальных популяций спинного мозга крыс после воздействия табачным дымом // Сибирское медицинское обозрение. 2015. №3. С.38-41

8. Camargo C.A. Jr, Boulet L.P., Sutherland E.R., Busse W.W., Yancey S.W., Emmett A.H., Ortega H.G., Ferro T.J. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast // J. Asthma. 2010. Vol.47, №1. P.76-82. doi: 10.3109/02770900903338494

9. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2014. URL: http://www.ginasthma.org

10. Jamieson C.A.M., Yamamoto K.R. Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling // Proc. Natl Acad. Sci. USA. 2000. Vol.97, №13. P.7319-7324.

11. Pelletier L., Guery J.C. Dihydropyridine receptor blockade in the treatment of asthma // Recent Pat. Inflamm. Allergy Drug Discov. 2008. Vol.2, №2. P.109-116.

12. Stern J.S., Hirsch J., Blair S.N., Foreyt J.P., Frank A., Kumanyika S.K., Madans J.H., Marlatt G.A., St Jeor S.T., Stunkard A.J. Weighting the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity // Obes. Res. 1995. Vol.3, №6. Р.591-604.

13. Vignola A.M., Chiappara G., Gagliardo R. Gjomarkaj M., Merendino A., Siena L., Bousquet J., Bonsignore G. Apoptosis and airway inflammation in asthma // Apoptosis. 2000. Vol.5, №5. P.473-485.

14. World Health Organization Media Centre. Obesity and overweight. Fact sheet No311. Geneva: WHO, 2013. URL: https://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight

15. Ageyeva Ye.S., Shtygasheva O.V., Iptyshev V.M., Butorin N.N., Tsukanov V.V., Ryazantseva N.V. The role apoptosis in dysregulations of lokal and system immunitet at the Helicobacter pilory-infection. Bulletin of Siberian Medicine 2010; 9(5):13-18 (in Russian). https://doi.org/10.20538/1682-0363-2010-5-13-18

16. Astaf'eva N.G., Gamova I.V., Udovichenko E.N., Perfilova I.A. Obesity and bronchial asthma. Lechashchiy vrach 2014; 4-5 (Pt 1-2) (in Russian).

17. Baidakova E.V., Unguryanu T.N., Buzinov R.V., Gudkov A.B. Bronchial asthma incidence among Arkhangelsk region population. Ekologiya cheloveka 2011; 12:8-13 (in Russian).

18. Kurbacheva O.M., Zhestkov A.V., Nagatkin D.A., Kulagina V.V., Nagatkina O.V. Modern view on immunopathogenesis of asthma. Russian Allergology Journal 2016; 2:10-14 (in Russian).

19. Nevzorova V.A., Pazych S.A., Barkhatova D.A., Kudryavtseva V.A The role of process cell death in course of inflammation under bronchial asthma. Pacific Medical Journal 2006; 2:54-58 (in Russian).

20. Skibo Y.V., Kurmaeva N.S. Apoptotic features of lymphocytes in patients with mild and severe atopic bronchial asthma. Prakticheskaya meditsina 2012; 6:62-68 (in Russian).

21. Ustinova T.I., Medvedeva N.N., Salmina A.B., Malinowskaya N.A. Morphological characteristics of neuro-glial populations of rat spinal cord following tobacco smoke exposure. Siberian Medical Review 2015;3:38-41 (in Russian).

22. Camargo C.A. Jr, Boulet L.P., Sutherland E.R., Busse W.W., Yancey S.W., Emmett A.H., Ortega H.G., Ferro T.J. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast. J. Asthma 2010; 47(1):76-82. doi: 10.3109/02770900903338494

23. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (Update 2014). Available at: www.ginasthma.com

24. Jamieson C.A.M., Yamamoto K.R. Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. Proc. Natl Acad. Sci. USA 2000; 97(13):7319-7324.

25. Pelletier L., Guery J.C. Dihydropyridine receptor blockade in the treatment of asthma. Recent Pat. Inflamm. Allergy Drug Discov. 2008; 2(2):109-116.

26. Stern J.S., Hirsch J., Blair S.N., Foreyt J.P., Frank A., Kumanyika S.K., Madans J.H., Marlatt G.A., St Jeor S.T., Stunkard A.J. Weighting the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Obes. Res. 1995; 3(6):591-604.

27. Vignola A.M., Chiappara G., Gagliardo R. Gjomarkaj M., Merendino A., Siena L., Bousquet J., Bonsignore G. Apoptosis and airway inflammation in asthma. Apoptosis 2000; 5(5):473-485.

28. World Health Organization Media Centre. Obesity and overweight. Fact sheet No311. Geneva: WHO; 2013. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight